fbpx An update on Mmr | Page 259 | Science in the net

An update on Mmr

Primary tabs

Read time: 1 min

Measles, mumps and rubella outbreaks still represent an healthcare issue, even though major advancements have been done towards their eradication. A poor inclination towards Mmr (measles-mumps-rubella) vaccination may constitute a major cause of increased risk to contract one of these diseases amongst specific population groups like migrants, alternative medicine users, some religious groups, healthcare professionals.
Information on Mmr vaccines coverage amongst these and others “hard-to-reach” groups was included in a document made and published Ecdc in range of the European project Venice II (Vaccine European New Integrated Collaboration Effort II). Main aim of the document was to provide a complete review of measles, mumps and rubella focuses which have been reported in the last twenty years in Europe.

Autori: 
Sezioni: 
Indice: 
Vaccination

prossimo articolo

Marie Curie grants: which country got more of them?

With a budget of 3.3 billions euro and over 15 thousand researcher involved between 2007 and 2013, the Marie Sklodowska-Curie Actions programme has been one of biggest research program in the EU.

Open to “researchers of all age and levels of experience, regardless of nationality”, it provides them different options – or “Actions”, as they're called – such as initial training for young scientists, partnerships with private enterprises, fellowships with a number of institutions in or outside Europe and more.